Improved diagnostic screening, integrated dialysis care protocols, and ongoing drug development focused on parathyroid hormone regulation are driving the global secondary hyperparathyroidism treatment market toward future growth. https://www.datamintelligence.com/research-report/secondary-hyperparathyroidism-treatment-market